CMB 0.00% 0.4¢ cambium bio limited

No surprises in there,Many eyes will be on MSB and its FDA GvHD...

  1. 7,513 Posts.
    lightbulb Created with Sketch. 6768
    No surprises in there,

    Many eyes will be on MSB and its FDA GvHD approval, If it does, that makes RGS' intellectual property stupidly cheap (as opposed to sillily cheap). Expect a raft of halo effect buying in the stem cell sector. Sadly mkts are that predictable. The FDA approval is not alas.....
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.